Eventide Asset Management, LLC Celldex Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

  • $5.67 Billion
  • Q3 2024

A detailed history of Eventide Asset Management, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 3,332,005 shares of CLDX stock, worth $87.3 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
3,332,005
Previous 3,327,132 0.15%
Holding current value
$87.3 Million
Previous $123 Million 8.08%
% of portfolio
1.99%
Previous 2.17%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$32.06 - $44.56 $156,228 - $217,140
4,873 Added 0.15%
3,332,005 $113 Million
Q2 2024

Aug 13, 2024
BUY
$32.76 - $42.56 $6.82 Million - $8.85 Million
208,045 Added 6.67%
3,327,132 $123 Million
Q1 2024

May 15, 2024
SELL
$35.22 - $51.88 $18 Million - $26.5 Million
-510,926 Reduced 14.08%
3,119,087 $131 Million
Q4 2023

Feb 14, 2024
BUY
$22.61 - $40.65 $45.9 Million - $82.5 Million
2,030,013 Added 126.88%
3,630,013 $144 Million
Q3 2023

Nov 14, 2023
BUY
$25.45 - $37.46 $5.66 Million - $8.33 Million
222,260 Added 16.13%
1,600,000 $44 Million
Q1 2023

May 15, 2023
SELL
$34.78 - $47.43 $2.97 Million - $4.05 Million
-85,310 Reduced 5.83%
1,377,740 $49.6 Million
Q4 2022

Feb 13, 2023
SELL
$27.78 - $45.38 $9.13 Million - $14.9 Million
-328,750 Reduced 18.35%
1,463,050 $65.2 Million
Q3 2022

Nov 14, 2022
BUY
$22.7 - $37.57 $7.86 Million - $13 Million
346,100 Added 23.94%
1,791,800 $50.4 Million
Q1 2022

May 16, 2022
BUY
$27.64 - $39.32 $5.72 Million - $8.13 Million
206,800 Added 16.69%
1,445,700 $49.2 Million
Q4 2021

Feb 14, 2022
BUY
$35.68 - $56.27 $3.96 Million - $6.24 Million
110,900 Added 9.83%
1,238,900 $47.9 Million
Q3 2021

Nov 15, 2021
SELL
$28.95 - $55.99 $28.4 Million - $54.9 Million
-980,908 Reduced 46.51%
1,128,000 $60.9 Million
Q2 2021

Aug 16, 2021
BUY
$20.71 - $35.37 $962,497 - $1.64 Million
46,475 Added 2.25%
2,108,908 $70.5 Million
Q1 2021

May 14, 2021
BUY
$16.19 - $29.91 $3.65 Million - $6.74 Million
225,325 Added 12.27%
2,062,433 $42.5 Million
Q4 2020

Feb 16, 2021
BUY
$14.99 - $22.75 $20 Million - $30.3 Million
1,330,929 Added 262.94%
1,837,108 $32.2 Million
Q3 2020

Nov 13, 2020
BUY
$9.65 - $15.19 $413,444 - $650,800
42,844 Added 9.25%
506,179 $7.51 Million
Q2 2020

Aug 14, 2020
BUY
$1.61 - $13.41 $745,969 - $6.21 Million
463,335 New
463,335 $6.02 Million

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.23B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email